Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies

M Polovina, C Tschöpe, G Rosano… - European Journal of …, 2023 - Wiley Online Library
Cardiomyopathies are a significant contributor to cardiovascular morbidity and mortality,
mainly due to the development of heart failure and increased risk of sudden cardiac death …

The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy: How to Guide Clinical Decision-Making?

M Khan, A Jahangir - Cardiology clinics, 2023 - cardiology.theclinics.com
Life-threatening cardiac dysrhythmias remain a significant cause of mortality in patients with
heart failure (HF). 1 Immediate cardioversion or defibrillation by implantable cardioverter …

Assessment of ICD eligibility in non-ischaemic cardiomyopathy patients: a position statement by the Task Force of the Dutch Society of Cardiology

ALCJ van der Lingen, TE Verstraelen… - Netherlands heart …, 2024 - Springer
International guidelines recommend implantation of an implantable cardioverter-defibrillator
(ICD) in non-ischaemic cardiomyopathy (NICM) patients with a left ventricular ejection …

Latest Advances in Delivery and Outcomes of Cardiac Resynchronization Therapy and Conduction System Pacing

AH Maass, F Daniëls, E Roseboom, K Vernooy… - Journal of Clinical …, 2023 - mdpi.com
Cardiac Resynchronization Therapy (CRT) is an established technique to improve morbidity
and mortality in selected heart failure patients. This technique has been a game changer for …

Implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy: a need or not?

JR de Groot - Netherlands Heart Journal, 2023 - Springer
In the Netherlands, sudden cardiac death (SCD), usually caused by ventricular fibrillation,
remains a major cause of mortality, with approximately 8000 cardiac arrests taking place …